INSTITUTION'S PROFILE

KalVista Pharmaceuticals, Cambridge, MA.

Publications (1)

"A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination".

Journal: The Journal of allergy and clinical immunology

Publication date: 

Journal: The Journal of allergy and clinical immunology

Publication Year: 

Authors & Co-authors:  Khalid Zektser Chu Li Utoh Ryan Loving Harb Kattappuram Chatman